These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2381875)

  • 21. Potentiation by thiorphan and bestatin of the naloxone-insensitive analgesic effects of neurotensin and neuromedin n.
    Coquerel A; Dubuc I; Kitaegi P; Costentin J
    Neurochem Int; 1988; 12(3):361-6. PubMed ID: 20501239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotensin blocks certain amphetamine-induced behaviours.
    Ervin GN; Birkemo LS; Nemeroff CB; Prange AJ
    Nature; 1981 May; 291(5810):73-6. PubMed ID: 7231526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the inhibitory effect of [D-Trp11]-NT toward some biological actions of neurotensin in rats.
    Rioux F; Kérouac R; St-Pierre S
    Neuropeptides; 1983 Jul; 3(5):345-54. PubMed ID: 6194472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of neurotensin on food consumption in the rat.
    Luttinger D; King RA; Sheppard D; Strupp J; Nemeroff CB; Prange AJ
    Eur J Pharmacol; 1982 Jul; 81(3):499-503. PubMed ID: 6811292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motor hypoactivity induced by neurotensin and related peptides in mice.
    Meisenberg G; Simmons WH
    Pharmacol Biochem Behav; 1985 Feb; 22(2):189-93. PubMed ID: 3983212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Centrally administered neurotensin suppresses locomotor hyperactivity induced by d-amphetamine but not by scopolamine or caffeine.
    Skoog KM; Cain ST; Nemeroff CB
    Neuropharmacology; 1986 Jul; 25(7):777-82. PubMed ID: 3748325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locomotor sensitization to [D-Trp(11)]neurotensin after repeated injections of the dopamine uptake inhibitor GBR12783 in rats.
    Boulay D; Duterte-Boucher D; Nouel D; Costentin J
    Neurosci Lett; 1996 Apr; 208(1):5-8. PubMed ID: 8731161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral effects of neurotensin in the open field: structure-activity studies.
    Elliott PJ; Chan J; Parker YM; Nemeroff CB
    Brain Res; 1986 Sep; 381(2):259-65. PubMed ID: 3756503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tonic suppression of baroreceptor reflex by endogenous neurotensin in the rat.
    Chen CT; Chan JY; Barnes CD; Chan SH
    Regul Pept; 1990 Mar; 28(1):23-37. PubMed ID: 2326505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central and peripheral involvement of endogenous opioid peptides in gastric protection in stressed rats.
    Scoto GM; Parenti C
    Pharmacology; 1996 Jan; 52(1):56-60. PubMed ID: 8966203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurotensin activates tuberoinfundibular dopamine neurons and increases serum corticosterone concentrations in the rat.
    Gudelsky GA; Berry SA; Meltzer HY
    Neuroendocrinology; 1989 Jun; 49(6):604-9. PubMed ID: 2549437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonization of fentanyl-induced muscular rigidity by neurotensin at the locus coeruleus of the rat.
    Wang SW; Tsou MY; Lee TY; Chan SH; Lui PW
    Regul Pept; 1994 Apr; 51(1):33-40. PubMed ID: 8036282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enkephalinase 'A' inhibition by thiorphan: central and peripheral cardiovascular effects.
    Baum T; Becker FT; Sybertz EJ; Sabin C; Desiderio DM
    Eur J Pharmacol; 1983 Oct; 94(1-2):85-91. PubMed ID: 6360696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of enkephalin degradation attenuated stress-induced motor suppression (conditioned suppression of motility).
    Nabeshima T; Katoh A; Kameyama T
    J Pharmacol Exp Ther; 1988 Jan; 244(1):303-9. PubMed ID: 3422094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotensin diminishes grooming and stimulates paper shredding behavior induced by water immersion of rats.
    Van Wimersma Greidanus TJ; Van Zinnicq Bergmann FF; Colbern DL
    Eur J Pharmacol; 1985 Jan; 108(2):201-3. PubMed ID: 4038942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible neuronal mechanisms involved in neurotensin-induced catalepsy in mice.
    Shibata K; Yamada K; Furukawa T
    Psychopharmacology (Berl); 1987; 91(3):288-92. PubMed ID: 2882538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptidase inhibitors potentiate the effects of neurotensin and neuromedin N on self-stimulation of the medial prefrontal cortex.
    Fernández R; Alba F; Ferrer JM
    Neuroreport; 1996 Feb; 7(3):798-800. PubMed ID: 8733748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmented analgesic effects of enkephalinase inhibitors combined with transcranial electrostimulation.
    Malin DH; Lake JR; Hamilton RF; Skolnick MH
    Life Sci; 1989; 44(19):1371-6. PubMed ID: 2716474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeated neurotensin administration in the ventral tegmental area: effects on baseline and D-amphetamine-induced locomotor activity.
    Elliott PJ; Nemeroff CB
    Neurosci Lett; 1986 Jul; 68(2):239-44. PubMed ID: 3748452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.